Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection & Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid tag derived from the influenza virus hemagglutinin protein, widely adopted in molecular biology for protein tagging and detection (APExBIO product page). This peptide exhibits high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) under laboratory conditions. It enables competitive elution of HA-tagged fusion proteins via specific anti-HA antibody binding, supporting robust immunoprecipitation and protein interaction workflows (Wei et al., 2021). The HA tag is stable when stored desiccated at -20°C and exhibits >98% purity verified by HPLC and mass spectrometry. These features facilitate reproducible, high-sensitivity assays in biochemical research and translational applications (Advanced Insights).

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide was developed as an epitope tag to facilitate the detection and purification of recombinant proteins. The HA epitope (YPYDVPDYA) is derived from the influenza A virus hemagglutinin protein, which is not endogenously present in most expression systems, minimizing background in detection (Wei et al., 2021). The peptide’s small size (9 amino acids) reduces the risk of steric hindrance or disruption to fusion partner protein function. This tag is recognized with nanomolar affinity by well-characterized monoclonal anti-HA antibodies, supporting both immunoprecipitation and immunodetection modalities. Protein tagging with the HA peptide is a cornerstone technique in studies of protein localization, trafficking, interaction, and post-translational modification. For advanced mechanistic detail on the HA tag in cancer signaling, see this in-depth review, which this article extends by providing detailed storage, solubility, and competitive binding parameters.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide functions as a competitive epitope for anti-HA antibodies. In immunoprecipitation workflows, anti-HA antibodies immobilized on beads capture HA-tagged fusion proteins from cell lysates. The addition of free HA peptide (e.g., APExBIO A6004) at concentrations sufficient to compete for antibody binding enables specific elution of the captured fusion protein. This process relies on the reversible, high-affinity interaction between the HA peptide and the antibody’s paratope (Cell Research, 2021). The competitive binding approach preserves protein complexes and interaction partners, supporting downstream analyses such as mass spectrometry or western blot. The peptide’s solubility profile (water, DMSO, ethanol) ensures compatibility with a wide range of buffer systems. For a practical guide to integrating HA peptide in assay workflows, see this scenario-driven Q&A, which this article updates with recent data on purity validation and storage best practices.

Evidence & Benchmarks

• The HA tag (YPYDVPDYA) is absent from most eukaryotic proteomes, enabling high-specificity detection in mammalian, yeast, and bacterial systems (Wei et al., 2021).
• The competitive elution protocol using 1 mg/mL HA peptide achieves >90% recovery of HA-tagged proteins from anti-HA beads within 30 minutes at 4°C (Fig. 2B).
• APExBIO's HA peptide (SKU A6004) is validated for >98% purity by HPLC and mass spectrometry, supporting sensitive downstream applications (product data).
• The peptide remains stable when stored desiccated at -20°C for at least 12 months; aqueous solutions should be prepared fresh to avoid hydrolysis (APExBIO).
• Solubility in common laboratory solvents: DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), water (≥46.2 mg/mL) supports flexible experimental design (data sheet).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is a versatile reagent for:

• Protein tagging: Fusion of the HA tag to recombinant proteins enables selective detection and purification.
• Immunoprecipitation: Competitive elution of HA-tagged proteins from anti-HA antibody matrices (scenario-driven insights).
• Protein-protein interaction studies: Preservation of protein complexes during gentle elution supports interactome mapping.
• Exosome research: Tagging exosome-associated proteins aids in vesicle tracking and cargo analysis (Wei et al., 2021).

The HA peptide does not interfere with most protein structures due to its small size, but fusion site (N- vs. C-terminal) and expression context should be empirically tested. For a comparison of the HA tag with other protein epitope tags and its role in translational protein science, see this thought-leadership piece, which this article clarifies by providing updated benchmarks and storage recommendations.

Common Pitfalls or Misconceptions

• Not a universal antibody epitope: The HA peptide is recognized only by anti-HA antibodies; it does not cross-react with other epitope tag antibodies.
• Does not function as an immunogen: The synthetic peptide is for in vitro use and will not reliably raise antibodies in vivo.
• Solution stability is limited: Long-term storage of peptide solutions at room temperature or 4°C leads to degradation; always prepare fresh aliquots.
• Potential interference with folded domains: Fusion of the HA tag within structured protein domains may disrupt protein function; validate tag placement empirically.
• Does not confer functional activity: The HA tag facilitates detection and purification but does not alter the biochemical activity of the fusion protein.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (A6004) from APExBIO is supplied as a lyophilized powder of >98% purity. It is soluble in DMSO, ethanol, and water, enabling preparation of concentrated stock solutions suitable for lab workflows. For immunoprecipitation, a typical working concentration is 1 mg/mL in elution buffer; incubation for 20–30 minutes at 4°C is recommended. The peptide can be used for competitive elution from anti-HA magnetic beads or agarose matrices. The recommended storage is desiccated at -20°C; avoid repeated freeze-thaw cycles and long-term storage of aqueous or DMSO solutions. For further optimization and troubleshooting scenarios, see Solving Assay Challenges with HA Peptide.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a gold-standard molecular biology reagent for protein tagging, detection, and purification. Its small size, high purity, and validated competitive binding underpin robust, reproducible workflows in protein science, exosome research, and biochemical assay development. As new recombinant technologies and interactome analyses emerge, the HA tag will continue to provide a reliable platform for mechanistic discovery. For ordering information, technical datasheets, and application guidance, visit the APExBIO Influenza Hemagglutinin (HA) Peptide product page.